Document is current
Any future updates will be listed below
-
Authors
Farschtschi, Said C. https://orcid.org/0000-0002-3596-5932
Kumps, Candy
Milagre, Tamara Hussong
Makrythanasis, Periklis https://orcid.org/0000-0002-3725-0113
Van Tongerloo, Ariane
Denayer, Ellen
van Kouwen, Mariëtte
Carrasco López, Estela
Berghoff, Anna Sophie
Testa, Salvo
Cesaretti, Claudia
Trevisson, Eva https://orcid.org/0000-0002-5380-6265
d’ Oliveira, Renata https://orcid.org/0000-0002-6469-7674
Fianchi, Francesca
Röhl, Claas
Salinas-Chaparro, Diana
Slegers, Ileen https://orcid.org/0000-0001-5907-829X
Geilswijk, Marianne
Suerink, Manon https://orcid.org/0000-0001-7058-6973
Spinelli, Irene
Janssens, Sandra
Pugh, Sarah
Sønderberg Roos, Laura Kirstine
- License Information
-
More Information
Article History
Received: 22 October 2025
Revised: 3 December 2025
Accepted: 15 December 2025
First Online: 13 January 2026
Competing interests
: All members of the ERN GENTURIS counselling on reproductive options guideline group, including the core working group, have provided disclosure statements on all relationships that they have that might be perceived to be a potential source of a conflict of interest. Said C. Farschtschi reported receipt of honoraria or consultation fees from Alexion and AstraZeneca. Tamara Hussong Milagre reported receipt of grant/research supports from Gilead Science (EVITA Platform) and receipt of honoraria or consultation fees from Novartis (Advisory Board). Claas Röhl reported receipt of grants/research supports from Boehringer Ingelheim, Alexion, BMS, Novartis, Roche, Tecan and participation in a company sponsored speaker’s bureau (Boehringer Ingelheim, Alexion). Anna Sophie Berghoff has research support from Daiichi Sankyo, Roche and honoraria for lectures, consultation or advisory board participation from Roche Bristol-Meyers Squibb, Merck, Daiichi Sankyo, AstraZeneca, CeCaVa, Seagen, Alexion, Servier, Pfizer, as well as travel support from Roche, Amgen and AbbVie. All participants of the ERN GENTURIS Counselling on reproductive options Delphi survey provided disclosure statements on all relationships that they have that might be perceived to be a potential source of competing interests. Rosie O Shea, Kerstin Rhiem, Sophie Frank, and Kleoniki Roka reported receipt of honoraria or consultation fees from AstraZeneca. Rosie O Shea reported participation in a company-sponsored speaker’s bureau: AstraZeneca. Kerstin Rhiem received grants/research support from German Cancer Society and received honoraria or consultation fees from Novartis, streamed up GmbH. Susanne Schüler-Toprak reported receipt of honoraria or consultation fees from Pfizer, Roche, GSK, and Celgene. Karin Wadt received honoraria or consultation fees from Seagen Denmark ApS. Sophie Frank reported travel support from Pharma, GSK, Lily, and Pfizer. Hildegunn Høberg Vetti reported receipt of honoraria or consultation fees from Pfizer AS, Novartis Norway AS, and Pierre Fabre Pharma Norden AB. Amedeo Azizi received grants/research supports from Alexion as well as honoraria or consultation fees from Alexion, Novartis, and Johnson & Johnson.
